Anti-PLA2R1 Antibodies as Prognostic Biomarker in Membranous Nephropathy

INTRODUCTION: Personalized treatment for patients with membranous nephropathy requires accurate prediction of the disease course at an early stage. In this study, we evaluated the value of baseline anti–phospholipase A2 receptor (PLA2R1) antibody titer as a prognostic biomarker in patients with PLA2...

Descripción completa

Detalles Bibliográficos
Autores principales: Logt, Anne-Els van de, Justino, Joana, Vink, Coralien H., van den Brand, Jan, Debiec, Hanna, Lambeau, Gérard, Wetzels, Jack F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207302/
https://www.ncbi.nlm.nih.gov/pubmed/34169209
http://dx.doi.org/10.1016/j.ekir.2021.04.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207302/
https://www.ncbi.nlm.nih.gov/pubmed/34169209
http://dx.doi.org/10.1016/j.ekir.2021.04.002

Ejemplares similares